TherapeuticsMD, Inc. Announces $8.5 Million Private Placement  
9/27/2012 9:45:32 AM

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD™, Inc. (OTCQB:TXMD), parent company of vitaMedMD®, LLC ("vitaMedMD"), a specialty pharmaceutical company ("TherapeuticsMD" or the "Company"), announced today that it entered into a definitive Securities Purchase Agreement with accredited investors covering an aggregate of 3,953,489 shares of the Company’s common stock in a private placement at a purchase price of $2.15 per share, which will result in aggregate gross proceeds to the Company of approximately $8.5 million.